VSIR and neoplasm: Moreover, when overexpressed in APCs from the tumour microenvironment, Dies1 actively suppressed T-cell proliferation, both in vitro and in vivo, leading to a decreased anti-tumoral immune response and promoting tumour growth in a T-cell dependent manner47.